Drug intelligence / Profile preview

Acesol Plus

Development stage
Unknown
Lead developer
Boffin Biotech
Modality
Small Molecules
Administration
Oral
01

Overview

Acesol Plus is an oral combination tablet containing the non-steroidal anti-inflammatory drug (NSAID) aceclofenac (100 mg) and the analgesic/antipyretic paracetamol (325 mg). Developed by Boffin Biotech, it is indicated for the short-term relief of pain, inflammation, and swelling associated with various musculoskeletal and joint disorders, such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. It is also used to alleviate acute pain from muscle strains, sprains, dental procedures, and headaches. Aceclofenac works by inhibiting cyclooxygenase (COX) enzymes, thereby blocking prostaglandin synthesis, while paracetamol acts centrally to reduce pain and fever.

Brand names
Acesol Plus
Other names
aceclofenac + paracetamolaceclofenac and paracetamolparacetamol + aceclofenac
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on Acesol Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acesol Plus.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call